C068:XETRA:XETRA-ComStage STOXX Europe 600 Health Care UCITS ETF (EUR)

ETF | Sector Equity Healthcare |

Last Closing

USD 145.26

Change

-0.28 (-0.19)%

Market Cap

USD 0.06B

Volume

2.09K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-04-08 )

Largest Industry Peers for Sector Equity Healthcare

ETFs Containing C068:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity Healthcare) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.65% 73% C 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return -6.65% 73% C 75% C
Trailing 12 Months  
Capital Gain -4.67% 18% F 63% D
Dividend Return 1.92% 50% F 32% F
Total Return -2.75% 27% F 67% D+
Trailing 5 Years  
Capital Gain 1.69% 43% F 62% D
Dividend Return 4.42% 50% F 21% F
Total Return 6.11% 43% F 63% D
Average Annual (5 Year Horizon)  
Capital Gain 3,235.02% 100% F 100% F
Dividend Return 3,235.84% 100% F 100% F
Total Return 0.83% 100% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 18,364.94% 8% B- N/A F
Risk Adjusted Return 17.62% 17% F 36% F
Market Capitalization 0.06B 27% F 29% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.